News | Robotic Systems | March 30, 2023

Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders.

Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders.

March 30, 2023 — Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation System to treat heart rhythm disorders.

“Advancing patient care is our number one priority, and we are excited to make this unique technology available, expanding our electrophysiology capabilities to treat the most complex heart arrhythmias with heightened precision,” said Ahmed Osman, M.D., Medical Director of Cardiac Electrophysiology.

The Genesis RMN system introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, certain arrhythmias can significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

“Broward Health is committed to adopting innovative technology and making it available to patients close to home,” said Shane Strum, President & CEO of Broward Health. “We are proud to be the first in Florida to introduce this system to further enhance the comprehensive range of advanced cardiac services we deliver to our community.”

“We are delighted to work with Broward Health as it pioneers this technology for the benefit of patients in Florida,” said David Fischel, Chairman and CEO of Stereotaxis. “We applaud their leadership and look forward to supporting their efforts to improve patient care and build a preeminent heart rhythm program.”

For more information: www.stereotaxis.com


Additional Content

Feature | EP Lab | Lars Thording, PhD

Medical device portfolios now move on two very different clocks. New technologies can gain clinical adoption within ...

Home October 14, 2026
Home
News | EP Lab

July 7, 2026 —AtaCor Medical has announced the enrollment of the first patient in the company's ALARION-EV trial ...

Home July 09, 2026
Home
News | EP Lab

April 17, 2026 — Corify Care has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for ...

Home April 20, 2026
Home
News | EP Lab

Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...

Home January 29, 2026
Home
News | EP Lab

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
Subscribe Now